Suggestions
Pranil Chandra
Vice President and Chief Medical Officer, Genomic and Clinical Pathology Services at PathGroup
Professional Background
Pranil Chandra is an accomplished physician leader who has made significant contributions to the fields of molecular and genomic pathology as well as clinical medicine. With extensive expertise in anatomic and clinical pathology, molecular genetic pathology, and hematopathology, Dr. Chandra has earned board certifications that reflect his commitment to clinical excellence. He currently serves as the Vice President and Chief Medical Officer of Genomic and Clinical Pathology Services at PathGroup, where he leads both the Molecular Pathology and Genomic Medicine Operations.
In his dynamic role, Dr. Chandra is responsible for providing clinical and administrative leadership that governs the operations of these critical divisions. His team oversees a considerable portion of PathGroup's revenue, accounting for approximately 60%. This highlights not only his leadership capabilities but also the strategic importance of molecular and genomic testing in today’s healthcare landscape.
Dr. Chandra has also acted as an internal and external consultant on various initiatives, guiding molecular test selection, developing new molecular biomarker tests, and ensuring the standardization of algorithmic testing practices. His work in promoting appropriate molecular test utilization is vital to enhancing patient care pathways and exemplifying the value of Personalized and Precision Medicine. His collaborative efforts include working with notable pharmaceutical affiliates like Pfizer, Bristol-Myers Squibb, AstraZeneca, and Roche, showcasing his stature as a thought leader in the adoption of cutting-edge medical strategies.
Throughout his tenure at PathGroup, which spans over five years, Dr. Chandra has been instrumental in the division’s growth and recognition at a national level. Under his leadership, the organization has performed over 1 million genomic tests and close to 6 million clinical pathology tests annually. His efforts have led to a doubling of net revenues and a substantial global reduction in operational testing costs, emphasizing his capability to drive both clinical outcomes and fiscal efficiency.
Education and Achievements
Pranil Chandra's educational journey is impressive and reflects a commitment to academic excellence. He studied at the prestigious New York College of Osteopathic Medicine, where he earned his Doctor of Osteopathy (DO) degree. After completing his doctorate, Dr. Chandra advanced his expertise in pathology through fellowship training at the esteemed MD Anderson Cancer Center, focusing on areas such as Molecular Genetic Pathology and Oncologic Surgical Pathology.
Prior to his medical training, Dr. Chandra completed his Bachelor of Science degree at Cornell University, a foundational experience that set the stage for his future in medicine and pathology. This strong educational background has undoubtedly played a vital role in shaping his professional acumen and his approach to leading innovative medical practices.
Achievements
Dr. Chandra has accumulated numerous accolades throughout his career that underscore his impact in the medical field. His leadership at PathGroup has earned national recognition for the division, which is no small feat in the ever-evolving landscape of molecular diagnostics. His contributions not only resulted in significant increases in testing volumes but also enhanced the integrity and reliability of the testing services provided.
In alignment with his commitment to advancing medical science, Dr. Chandra has implemented strategies that encourage the integration of molecular biomarker testing into community practice. Through his consultancy efforts, he has been a catalyst for transforming molecular testing from specialized laboratory centers to more accessible points of care, demonstrating a vested interest in the growth and standardization of molecular diagnostics.
Dr. Chandra's innovative approach has made him a sought-after speaker and consultant, providing insights that help reshape corporate molecular business strategies. His passion for Personalized and Precision Medicine stems from a deep-seated belief in the potential of tailored treatments to improve patient outcomes, a goal that remains at the forefront of his professional endeavors.
In summary, Dr. Pranil Chandra’s vast experience, leadership roles, and dedication to enhancing the fields of molecular and clinical pathology place him at the forefront of this industry. His professional journey is marked by a consistent commitment to clinical excellence, innovative thinking in pathology services, and significant contributions towards the promotion of Personalized and Precision Medicine.
Education
- Doctor of Osteopathy (DO), New York College of Osteopathic Medicine
- Fellowship Certification in Molecular Genetic Pathology, Oncologic Surgical Pathology, and Molecular Genetic Pathology at MD Anderson Cancer Center
- Bachelor of Science, Cornell University
Career Highlights
- Vice President and Chief Medical Officer, Genomic and Clinical Pathology Services, PathGroup
- Former AVP Medical Director, Molecular Pathology and Genomic Medicine Services, PathGroup
- Former Director, Molecular Pathology Services, PathGroup
- Former Associate Medical Director, Molecular Pathology, PathGroup
- Former Pathologist, Medical Director of Molecular Diagnostics-Wisconsin, Great Lakes Pathologists, S.C.
- Former Chief Fellow, MD Anderson Cancer Center
- Former Fellow and House Officer at NYU Langone Medical Center
- Former Rotating Internship, Long Beach Medical Center